Conakry

Worldwide: Tracking the spread of the novel coronavirus

Mon, 2020-07-20 06:22 — mike kraft

Tracking the spread of the novel coronavirus Reuters maps all places where COVID-19 cases have been confirmed. Gurman Bhatia Reuters

At least 605,782 people globally have died from COVID-19 and 14,576,899 have been infected by the novel coronavirus that causes it, following an outbreak that started in Wuhan, China, in early December. The World Health Organization referred to it as a pandemic on March 11, 2020.

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Worldwide: Tracking the spread of the novel coronavirus
Log in or register to post comments

Global surge in coronavirus cases is being fed by the developing world — and the U.S.

Wed, 2020-07-15 06:40 — mike kraft

Global surge in coronavirus cases is being fed by the developing world — and the U.S. While some areas have recovered, case counts are hitting new highs in many regions. Griff Witte, Mary Beth Sheridan, Joanna Slater, Liz Sly

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Global surge in coronavirus cases is being fed by the developing world — and the U.S.
Log in or register to post comments

Ebola: as ZMapp stocks run out doctors turn to alternative treatments

Mon, 2015-01-05 12:50 — mike kraft

THE GUARDIAN by Sarah Boseley Jan, 5, 2015
LONDON --Even at the Royal Free hospital in London, the lead UK specialist centre for Ebola, doctors have limited options for treating their patients. In the end, survival may depend more on the strength of an individual’s immune system than anything medical science is currently able to do.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ebola: as ZMapp stocks run out doctors turn to alternative treatments
Log in or register to post comments

FDA allows testing of Aethlon device in Ebola patients

Fri, 2015-01-02 08:34 — mike kraft

REUTERS Jan. 2, 2015

SAN DIEGO- Calif. --Aethlon Medical Inc said the U.S. Food and Drug Administration had approved the testing in Ebola patients of its bio-filtration device, which was used against the deadly virus in a critically ill patient in Germany who later recovered.

The device, being developed as a broad-spectrum countermeasure against pandemic threats, filters viruses and toxins from the blood.

It is currently being tested in India for its ability to accelerate viral load depletion when used in combination with hepatitis C standard-of-care drug therapy.

Patients will be treated for six to eight hours daily with the device, called Aethlon's Hemopurifier, until the Ebola viral load drops below 1,000 copies/ml.

Read complete story.
http://www.reuters.com/article/2015/01/02/health-ebola-aethlon-med-idUSL3N0UH15720150102

Country / Region Tags:

General Topic Tags: